Specialty pharmacists play critical role in supporting treatment adherence.
2022
Rise in non-harmful melanoma detection
A video of two men claiming to show viewers how to get off with driving under the influence is gaining traction online – but all is not as it seems.
Study Aims to Identify Melanoma Patients With High-Risk Disease
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Patients with early-stage melanoma with low disease burden sentinel node (SN) micrometastases (American Joint Committee on Cancer [AJCC] stage IIIA disease) with SN tumor deposits ?0.3 mm have lower survival, according to a study published online July 18 in the Journal of Clinical Oncology.
Low-Dose Methotrexate Exposure Minimally Increases Risk of Melanoma
“Comprehensively defining the risk of melanoma associated with low-dose methotrexate is important for clinicians across several medical disciplines."